Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Buys $1,838,834.12 in Stock

Key Points

• L1 Capital Pty Ltd purchased 236,354 Anteris Technologies Global shares at an average price of $7.78, a transaction valued at approximately $1.84 million. The major shareholder subsequently owned 12.13 million shares worth about $94.4 million.
• The purchase was part of a broader buying spree in late September and early October, including more than $4.87 million spent on October 5. AVR shares opened at $7.55, down 2.1%, and remain below their 50-day moving average.
• Anteris reported a quarterly loss of $0.30 per share and revenue of $1.01 million, both worse than analyst expectations. Despite the weak results and a “sell” rating from Weiss Ratings, analysts maintained a “Moderate Buy” consensus with a $16 average price target.

Anteris Technologies Global Corp. (NASDAQ:AVR - Get Free Report) major shareholder L1 Capital Pty Ltd bought 236,354 shares of the company's stock in a transaction on Friday, October 2nd. The shares were acquired at an average price of $7.78 per share, with a total value of $1,838,834.12. Following the transaction, the insider directly owned 12,129,925 shares of the company's stock, valued at approximately $94,370,816.50. This trade represents a 1.99% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Large shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Monday, October 5th, L1 Capital Pty Ltd bought 648,455 shares of Anteris Technologies Global stock. The shares were acquired at an average cost of $7.51 per share, for a total transaction of $4,869,897.05.
• On Thursday, October 1st, L1 Capital Pty Ltd purchased 322,940 shares of Anteris Technologies Global stock. The stock was acquired at an average price of $7.60 per share, for a total transaction of $2,454,344.00.
• On Wednesday, September 30th, L1 Capital Pty Ltd purchased 74,286 shares of Anteris Technologies Global stock. The shares were acquired at an average cost of $7.72 per share, with a total value of $573,487.92.
• On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.83, for a total value of $68,874.00.
• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total value of $3,495,079.50.
• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.10, for a total value of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.23, for a total value of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total transaction of $3,853,113.30.

Anteris Technologies Global Trading Down 2.1%

NASDAQ AVR opened at $7.55 on Tuesday. The stock has a market cap of $735.82 million, a PE ratio of -3.87 and a beta of 1.87. Anteris Technologies Global Corp. has a 12 month low of $3.30 and a 12 month high of $11.06. The company's 50-day moving average price is $8.48 and its 200-day moving average price is $8.00.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.09). The company had revenue of $1.01 million for the quarter, compared to the consensus estimate of $1.50 million. Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. During the same quarter in the previous year, the business earned ($0.58) EPS. As a group, sell-side analysts forecast that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current year.

Institutional Trading of Anteris Technologies Global

Several hedge funds and other institutional investors have recently bought and sold shares of AVR. BlackRock Inc. purchased a new position in shares of Anteris Technologies Global in the 2nd quarter valued at $56,846,000. Nantahala Capital Management LLC purchased a new stake in shares of Anteris Technologies Global during the 2nd quarter worth $33,325,850. ADAR1 Capital Management LLC bought a new stake in Anteris Technologies Global during the second quarter valued at about $30,979,000. Perceptive Advisors LLC boosted its position in Anteris Technologies Global by 104.4% during the first quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company's stock valued at $19,011,000 after purchasing an additional 1,750,000 shares in the last quarter. Finally, Assenagon Asset Management S.A. purchased a new position in Anteris Technologies Global in the second quarter valued at about $6,350,000.

Wall Street Analyst Weigh In

AVR has been the subject of a number of research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of Anteris Technologies Global in a report on Wednesday, August 26th. Cantor Fitzgerald restated an "overweight" rating and set a $15.00 price objective on shares of Anteris Technologies Global in a report on Friday, August 14th. Four analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $16.00.

About Anteris Technologies Global

Anteris Technologies Global is a clinical-stage structural heart company developing technologies intended to treat aortic valve disease. The company's lead product is the DurAVR transcatheter heart valve, which is designed to replicate the performance characteristics of a healthy human aortic valve and restore more natural blood flow.

Anteris uses its proprietary ADAPT tissue-engineering technology to create heart-valve materials designed for durability and biocompatibility. The company is focused primarily on transcatheter aortic valve replacement and related structural-heart applications, with its products progressing through clinical development and regulatory evaluation rather than broad commercial distribution.

The company has Australian origins and maintains operations and clinical-development activities in both Australia and the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.